NP3-31810-50401 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-27
Dose 1 — Pfizer-BioNTech
2021-02-16
Registered in v-safe
2021-02-16
Dose 2 — Pfizer-BioNTech
2021-02-16
Health check-in — 0 day, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-02-17
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-02-18
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-03-09
Health check-in — 21 day, dose 2
Feeling: Good

Adult check-in
2021-05-18
Health check-in — 3 month, dose 2
Feeling: Good

Adult check-in
2022-02-16
Survey response — 12 month, dose 2
MedDRA: Extrasystoles, Menstruation irregular — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

MedDRA releases: 2024-11 · check-in answers available
2022-02-16
Report sent to call center — 12 month, dose 2
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-02-17
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-27	Pfizer-BioNTech
2	2021-02-16	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2022-02-16	Unsuccessful

Free text

Release 11

Symptoms: Irregular menstrual cycles and increased heart ectopic beats

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Extrasystoles	·	·	✓
SD	Menstruation irregular	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release